{"id":"W2946486395","doi":"10.1016/s1470-2045(19)30091-9","title":"Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Open label; Medicine; Internal medicine; Oncology; Lymphoma; Brentuximab vedotin; Phases of clinical research; Diffuse large B-cell lymphoma; Clinical trial; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004977711,0.0002726046,0.000996538,0.0001226294,0.00006300402,0.00003774616,0.0003251811,0.0001039798,0.00003946995],"category_scores_gemma":[0.00001325849,0.0001504135,0.00001829426,0.000348493,0.00005122146,0.0001557085,0.00007483771,0.000139923,0.00003576153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007944297,"about_ca_system_score_gemma":0.0003066534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001004818,"about_ca_topic_score_gemma":0.001360754,"domain_scores_codex":[0.9981377,0.0003985842,0.0003503242,0.0004231682,0.000228165,0.0004621254],"domain_scores_gemma":[0.9987499,0.0001728795,0.000218195,0.0006897876,0.00008953488,0.00007975811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.07708689,0.2574987,0.6565954,0.000026202,0.0001620772,0.0001248529,0.003636841,0.000001965351,0.0001233874,0.00003097033,0.00006433398,0.004648412],"study_design_scores_gemma":[0.5755265,0.02941993,0.3938788,0.00007395621,0.00009068096,0.000006250712,0.0003587066,0.0001508618,0.0001267765,0.000007889273,0.0002399678,0.0001196353],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911921,0.0001305851,0.000002082291,0.0004010086,0.00005950063,0.006889974,0.00001240315,0.00003050552,0.001281834],"genre_scores_gemma":[0.9981705,0.00006690197,0.0001376649,0.0007352195,0.00002805607,0.000497085,0.0001835188,0.00004236451,0.0001386705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4984397,"threshold_uncertainty_score":0.6133686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01880862093623526,"score_gpt":0.3208220799402624,"score_spread":0.3020134590040272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}